3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
181
Breast Neoplasms
154
Prostatic Neoplasms
144
Lung Neoplasms
139
Glioblastoma
119
Head and Neck Neoplasms
115
Squamous Cell Carcinoma of Head and Neck
110
Rectal Neoplasms
107
Lymphoma
101
Esophageal Neoplasms
100
Pancreatic Neoplasms
76
Esophageal Squamous Cell Carcinoma
71
Leukemia
70
Neoplasms
67
Brain Neoplasms
67
Lymphoma, Follicular
63
Precursor Cell Lymphoblastic Leukemia-Lymphoma
62
Lymphoma, Non-Hodgkin
62
Lymphoma, Large B-Cell, Diffuse
58
Hodgkin Disease
56
Uterine Cervical Neoplasms
53
Central Nervous System Neoplasms
53
Leukemia, Lymphocytic, Chronic, B-Cell
52
Gliosarcoma
51
Sarcoma
50
Colorectal Neoplasms
50
Neoplasm Metastasis
45
Lymphoma, Large-Cell, Immunoblastic
45
Glioma
44
Burkitt Lymphoma
43
Interventions
Human Papillomavirus Recombinant Vaccine nonavalent
9
Papillomavirus Vaccines
8
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
8
Surveys and Questionnaires
6
Educational Status
6
Blood Specimen Collection
5
Vaginal Smears
4
Radiotherapy, Intensity-Modulated
4
Methods
4
Human Papillomavirus DNA Tests
4
Early Intervention, Educational
4
Cisplatin
4
Carboplatin
4
Patient Navigation
3
Mass Screening
3
Taxes
2
Standard of Care
2
Radiation
2
Practice Guidelines as Topic
2
Papanicolaou Test
2
Paclitaxel
2
Motivational Interviewing
2
Interviews as Topic
2
Electrocoagulation
2
Docetaxel
2
Cytological Techniques
2
Cryotherapy
2
Colposcopy
2
utomilumab
1
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Papillomavirus Infections
×
Radiotherapy
×
Clear all
NCT02258659
2024-09-24
OPTIMA
University of Chicago
Phase 2
Completed
62 enrolled
13 charts